Achillion Pharmaceuticals Stock Number Of Shares Shorted
Achillion Pharmaceuticals fundamentals help investors to digest information that contributes to Achillion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Achillion Pink Sheet. The fundamental analysis module provides a way to measure Achillion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achillion Pharmaceuticals pink sheet.
Achillion |
Achillion Pharmaceuticals Company Number Of Shares Shorted Analysis
Achillion Pharmaceuticals' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Achillion Pharmaceuticals Number Of Shares Shorted | 16.38 M |
Most of Achillion Pharmaceuticals' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achillion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Achillion Pharmaceuticals has 16.38 M of outstending shares currently sold short by investors. This is 165.38% higher than that of the Communication Services sector and significantly higher than that of the Advertising Agencies industry. The number of shares shorted for all United States stocks is significantly lower than that of the firm.
Achillion Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achillion Pharmaceuticals' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Achillion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Achillion Pharmaceuticals by comparing valuation metrics of similar companies.Achillion Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers.
Achillion Fundamentals
| Return On Equity | -0.0023 | |||
| Return On Asset | -115.43 | |||
| Operating Margin | (586.17) % | |||
| Current Valuation | 6.21 M | |||
| Shares Outstanding | 30 M | |||
| Shares Owned By Insiders | 97.61 % | |||
| Number Of Shares Shorted | 16.38 M | |||
| Price To Earning | (23.49) X | |||
| Price To Book | 4.00 X | |||
| Price To Sales | 710.14 X | |||
| Revenue | 8.7 K | |||
| Gross Profit | 7.87 K | |||
| EBITDA | (43.34 K) | |||
| Net Income | (51 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Total Debt | 61 K | |||
| Debt To Equity | 1.00 % | |||
| Current Ratio | 0.02 X | |||
| Cash Flow From Operations | (39.76 K) | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (0) X | |||
| Price To Earnings To Growth | (0.66) X | |||
| Number Of Employees | 56 | |||
| Beta | 1.59 | |||
| Market Capitalization | 6.18 M | |||
| Total Asset | 464.52 M | |||
| Retained Earnings | (653.45 M) | |||
| Working Capital | 447.93 M | |||
| Current Asset | 462.59 M | |||
| Current Liabilities | 14.66 M | |||
| Z Score | 59.2 |
Pair Trading with Achillion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Achillion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achillion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Visa could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Visa when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Visa - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Visa Class A to buy it.
The correlation of Visa is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Visa moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Visa Class A moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Visa can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |